What did @aprilmj.journey actually say?
Honestly? Nothing. The transcript for this video appears to be lyrics or garbled audio, not medical commentary. The words attributed to @aprilmj.journey, "Bitchin' by problems like a stuck on your lips / You're so dramatic," read like a pop song fragment, not a GLP-1 health claim. There is no identifiable medical assertion here to fact-check.
The caption offers a promo code and nothing else. Without hearing an actual health claim, attributing a stance on semaglutide, tirzepatide, or any other GLP-1 medication to this creator would be irresponsible. This review will instead cover what viewers searching GLP-1 content on TikTok are most commonly exposed to, so you know what to watch for.
Does the science back this up?
There is no claim to evaluate against the literature. That said, the GLP-1 space on TikTok is a minefield worth mapping. A 2023 analysis published in PLOS ONE by Chatterjee et al. found that a significant portion of weight-loss related TikTok content contained inaccurate or misleading health information, with creator credibility rarely disclosed.
GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) have robust clinical evidence behind them. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide achieving up to 22.5% body weight reduction in adults with obesity. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide producing roughly 15% weight loss. These are real results from real trials. What TikTok often gets wrong is the framing around access, dosing, and compounded alternatives.
What did they get wrong (or right)?
There is nothing in this transcript to credit or correct on medical grounds. The video, as transcribed, makes zero health claims. What we can flag is the promotional structure: a promo code in the bio attached to GLP-1 category content is a common pattern for affiliate-linked telehealth or compounded medication referrals.
That matters because viewers may not distinguish between branded FDA-approved semaglutide and compounded semaglutide salts. These are not equivalent products. The FDA has explicitly warned that compounded semaglutide products are not the same as Ozempic or Wegovy and carry unverified quality and dosing risks. Any creator pushing a referral code in this category, without disclosing what product they are promoting or whether it is compounded, is leaving viewers without information they genuinely need to make safe choices.
What should you actually know?
If you landed here from a GLP-1 TikTok with a promo code, slow down before clicking. Here is what matters. First, compounded semaglutide is not FDA-approved. It was permitted under shortage provisions, but the FDA removed semaglutide from its drug shortage list in early 2025, which triggered enforcement action against most compounders. The legal and safety landscape for compounded GLP-1s has shifted substantially.
Second, GLP-1 medications require clinical oversight. Side effects including nausea, vomiting, gastroparesis, and pancreatitis are real and dose-dependent. The SCALE and STEP trials consistently showed that adverse events increased with faster titration. Third, a promo code is not a prescription. Anyone offering GLP-1 access through a referral link should be putting you through a real intake process with a licensed prescriber, not just a checkout flow. If the path to a prescription feels like buying a supplement, that is a problem worth taking seriously.